Quarterly report · Q2
6788.TEDINET S100PL9E
Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥9.1bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥16.3bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥8.4bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥1.2bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥1.2bn | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥1.3bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.1bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.3bn | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.3bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.3bn | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥848m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.9bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.5bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥926m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥1.5bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥27.5bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥26.6bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥26.0bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥6.2bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥5.8bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥21.4bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥20.8bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥20.5bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥12.9bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥11.9bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥12.9bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.9bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.4bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.7bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥254m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥232m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥432m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥659m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥486m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥568m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥802m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥110.6 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥67.94 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥250.58 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥187.25 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥101.75 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 73.7% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.5% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.2% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 18
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E02333-000Medical Relatedreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E02333-000Medical Relatedreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E02333-000Medical Relatedreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥138m |
| jpcrp040300-q2r_E02333-000Water Health Carereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥7.9bn |
| jpcrp040300-q2r_E02333-000Water Health Carereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥7.9bn |
| jpcrp040300-q2r_E02333-000Water Health Carereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥1.1bn |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥9.1bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥9.1bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E02333-000Medical Relatedreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥938m |
| jpcrp040300-q2r_E02333-000Medical Relatedreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥938m |
| jpcrp040300-q2r_E02333-000Medical Relatedreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥81m |
| jpcrp040300-q2r_E02333-000Water Health Carereportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥7.5bn |
| jpcrp040300-q2r_E02333-000Water Health Carereportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥7.5bn |
| jpcrp040300-q2r_E02333-000Water Health Carereportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥1.1bn |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥8.4bn |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥8.4bn |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | ¥1.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 503
| Item | Context | Value | Unit |
|---|---|---|---|
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |